The Potential Therapeutic Role of for Treatment of Inflammatory Bowel Disease

Overview

Journal Foods

Specialty Biotechnology

Date 2023 Feb 25

PMID 36832767

Authors

Hang Guo

Leilei Yu

Fengwei Tian

Wei Chen

Qixiao Zhai

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD) is a heterogeneous group of diseases associated with chronic inflammation of the intestinal tract, and is highly prevalent worldwide. Although its origin is not yet fully understood, new evidence emphasizes that environmental factors, especially dietary factors and intestinal microbiota disorders are key triggers of IBD. Probiotics, such as spp., play an essential role in human health as they exert beneficial effects on the composition of the human gastrointestinal microbial community and immune system. Probiotic-based therapies have been shown to be effective in alleviating IBD. Among these, is one of the most widely used strains. is widely present in the intestines of healthy individuals; it regulates the intestinal immune system and reduces inflammation through a variety of mechanisms. The purpose of this study was to identify scientific evidence related to and IBD, review and summarize the results, and discuss the possible mechanisms of action as a starting point for future research on IBD treatment.

Citing Articles

Restore intestinal steady-state: new advances in the clinical management of chemotherapy-associated diarrhea and constipation.

Chen M, Li Y, Chen P J Mol Histol. 2025; 56(2):101.

PMID: 40056250 PMC: 11890403. DOI: 10.1007/s10735-025-10367-w.

Probiotic Characterization of Lactic Acid Bacteria from Donkey Feces in China.

Wu Y, Yue S, Yu J, Bian F, Chen G, Zhang Y Animals (Basel). 2025; 15(2).

PMID: 39858207 PMC: 11758317. DOI: 10.3390/ani15020207.

Bacillus licheniformis B410 Alleviates Inflammation Induced by Lipopolysaccharide and Salmonella by Inhibiting NF-κB and IRF Signaling Pathways in Macrophages.

Xiong D, Sun T, Liu M, Wang B, Guan T, Song L Probiotics Antimicrob Proteins. 2024; .

PMID: 39739164 DOI: 10.1007/s12602-024-10440-y.

Gut-Brain Axis and Neuroinflammation: The Role of Gut Permeability and the Kynurenine Pathway in Neurological Disorders.

Kearns R Cell Mol Neurobiol. 2024; 44(1):64.

PMID: 39377830 PMC: 11461658. DOI: 10.1007/s10571-024-01496-z.

Paraprobiotic derived from GV1 improves immune response and gut microbiota composition in cyclophosphamide-treated immunosuppressed mice.

Lee H, Tran M, Le M, Justine E, Kim Y Front Immunol. 2024; 15:1285063.

PMID: 38455053 PMC: 10918466. DOI: 10.3389/fimmu.2024.1285063.

References

Fedorak R, Feagan B, Hotte N, Leddin D, Dieleman L, Petrunia D . The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease. Clin Gastroenterol Hepatol. 2014; 13(5):928-35.e2. DOI: 10.1016/j.cgh.2014.10.031. View

von Ossowski I, Reunanen J, Satokari R, Vesterlund S, Kankainen M, Huhtinen H . Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Appl Environ Microbiol. 2010; 76(7):2049-57. PMC: 2849237. DOI: 10.1128/AEM.01958-09. View

Liu Z, Liu F, Wang W, Sun C, Gao D, Ma J . Study of the alleviation effects of a combination of Lactobacillus rhamnosus and inulin on mice with colitis. Food Funct. 2020; 11(5):3823-3837. DOI: 10.1039/c9fo02992c. View

Lin P, Myers L, Ray L, Song S, Nasr T, Berardinelli A . Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med. 2009; 47(8):1205-11. PMC: 2760264. DOI: 10.1016/j.freeradbiomed.2009.07.033. View

Celiberto L, Bedani R, Rossi E, Cavallini D . Probiotics: The scientific evidence in the context of inflammatory bowel disease. Crit Rev Food Sci Nutr. 2015; 57(9):1759-1768. DOI: 10.1080/10408398.2014.941457. View

Harrington S, Strauman M, Abe C, Nataro J . Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. Cell Microbiol. 2005; 7(11):1565-78. DOI: 10.1111/j.1462-5822.2005.00588.x. View

Zeng M, Inohara N, Nunez G . Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2016; 10(1):18-26. PMC: 5788567. DOI: 10.1038/mi.2016.75. View

Gupta P, Andrew H, Kirschner B, Guandalini S . Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr. 2000; 31(4):453-7. DOI: 10.1097/00005176-200010000-00024. View

Xu L, Liu B, Huang L, Li Z, Cheng Y, Tian Y . Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model. Microbiol Spectr. 2022; 10(4):e0065722. PMC: 9430814. DOI: 10.1128/spectrum.00657-22. View

10.

Vong L, Lorentz R, Assa A, Glogauer M, Sherman P . Probiotic Lactobacillus rhamnosus inhibits the formation of neutrophil extracellular traps. J Immunol. 2014; 192(4):1870-7. DOI: 10.4049/jimmunol.1302286. View

11.

Ouwehand A, Saxelin M, Salminen S . Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin Infect Dis. 2004; 39(12):1858-60. DOI: 10.1086/425741. View

12.

Pang B, Jin H, Liao N, Li J, Jiang C, Shao D . from human breast milk ameliorates ulcerative colitis in mice gut microbiota modulation. Food Funct. 2021; 12(11):5171-5186. DOI: 10.1039/d0fo03479g. View

13.

Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K . Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. PMC: 3491803. DOI: 10.1038/nature11582. View

14.

Malin M, Suomalainen H, Saxelin M, Isolauri E . Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab. 1996; 40(3):137-45. DOI: 10.1159/000177907. View

15.

Zocco M, Zileri Dal Verme L, Cremonini F, Piscaglia A, Nista E, Candelli M . Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 2006; 23(11):1567-74. DOI: 10.1111/j.1365-2036.2006.02927.x. View

16.

Yang L, Higginbotham J, Liu L, Zhao G, Acra S, Peek Jr R . Production of a Functional Factor, p40, by Lactobacillus rhamnosus GG Is Promoted by Intestinal Epithelial Cell-Secreted Extracellular Vesicles. Infect Immun. 2019; 87(7). PMC: 6589071. DOI: 10.1128/IAI.00113-19. View

17.

Mirkov M, Verstockt B, Cleynen I . Genetics of inflammatory bowel disease: beyond NOD2. Lancet Gastroenterol Hepatol. 2017; 2(3):224-234. DOI: 10.1016/S2468-1253(16)30111-X. View

18.

Wan C, Qian W, Liu W, Pi X, Tang M, Wang X . Exopolysaccharide from Lactobacillus rhamnosus ZFM231 alleviates DSS-induced colitis in mice by regulating gut microbiota. J Sci Food Agric. 2022; 102(15):7087-7097. DOI: 10.1002/jsfa.12070. View

19.

Sandborn W, Feagan B, Marano C, Zhang H, Strauss R, Johanns J . Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2013; 146(1):85-95. DOI: 10.1053/j.gastro.2013.05.048. View

20.

Levine A, Sigall Boneh R, Wine E . Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018; 67(9):1726-1738. DOI: 10.1136/gutjnl-2017-315866. View